Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Sees Significant Decline in Short Interest

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the recipient of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 100 shares, a decrease of 75.0% from the December 15th total of 400 shares. Based on an average daily trading volume, of 3,100 shares, the short-interest ratio is presently 0.0 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Trading Up 0.5 %

NASDAQ HROWM traded up $0.13 during trading hours on Monday, reaching $26.76. 3,527 shares of the stock traded hands, compared to its average volume of 4,632. The stock has a 50 day simple moving average of $26.24 and a two-hundred day simple moving average of $26.35. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 1 year low of $25.29 and a 1 year high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Wednesday, January 15th will be issued a dividend of $0.7422 per share. The ex-dividend date of this dividend is Wednesday, January 15th. This represents a $2.97 dividend on an annualized basis and a dividend yield of 11.09%.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.